About
Therapies for inflammatory and immunological diseases
Areas of Focus
Categories
Biologics & Biopharmaceutical
Team (12)
Beth Alley
Beth Alley
Revolo Biotherapeutics
team_member
Femi Oluboyede
Femi Oluboyede
Revolo Biotherapeutics
team_member
Glen Giovanetti
Glen Giovanetti
Revolo Biotherapeutics
team_member
Jonathan Gold
Jonathan Gold
Revolo Biotherapeutics
team_member
Jones W Bryan
Jones W Bryan, ph.d.
Revolo Biotherapeutics
team_member
Jorge De Alba
Jorge De Alba, ph.d.
Revolo Biotherapeutics
team_member
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
141
By Phase
PHASE1: 2PHASE2: 2
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05921591Lead Sponsor
Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy Volunteers
PHASE1Completed
24 participants
Started: May 26, 2023 · Completed: Sep 12, 2023
NCT05098522Lead Sponsor
Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis
PHASE2Completed
63 participants
Started: Nov 4, 2021 · Completed: Mar 27, 2023
NCT05084963Lead Sponsor
A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis
PHASE2Completed
36 participants
Started: Oct 29, 2021 · Completed: Oct 24, 2022
NCT04748536Lead Sponsor
Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers
PHASE1Completed
18 participants
Started: Jan 29, 2021 · Completed: Apr 5, 2021
Locations (1)
Headquarters
Cambridge, UK
Map
Loading map...